Международные клинические рекомендации по ведению пациентов с неварикозными кровотечениями из верхних отделов желудочно-кишечного тракта: Литература
СтатьиAlan N. Barkun, Marc Bardou, Ernst J. Kuipers, Joseph Sung, Richard H. Hunt, Myriam Martel, Paul Sinclair,
Предыдущий раздел | Содержание
ЛИТЕРАТУРА
1. Lewis JD, Bilker WB, Brensinger C, Farrar JT, Strom BL. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol. 2002;97:2540-9. [PMID: 12385436]
2. Targownik LE, Nabalamba A. Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993-2003. Clin Gastroenterol Hepatol. 2006;4:1459-1466. [PMID: 17101296]
3. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol. 2006;101:945-53. [PMID: 16573778]
4. Zhao Y, Encinosa W. Hospitalizations for gastrointestinal bleeding in 1998 and 2006. HCUP Statistical Brief 65. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
5. van Leerdam ME, Vreeburg EM, Rauws EA, Geraedts AA, Tijssen JG, Reitsma JB, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/ 1994 and 2000. Am J Gastroenterol. 2003;98:1494-9. [PMID: 12873568]
6. Dalton D, Grant-Casey J, Hearnshaw S, Lowe D, Travis S, Rockall T, et al. The UK comparative audit of upper gastrointestinal bleeding and the use of blood. Oxford, UK: National Blood Service; 2007.
7. Adam V, Barkun A. Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health. 2008; 11:1-3.
8. Lanas A, Garci'a-Rodri'guez LA, Polo-Toma's M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104: 1633-41. [PMID: 19574968]
9. Barkun A, Sabbah S, Enns R, Armstrong D, Gregor J, Fedorak RN, et al; RUGBE Investigators. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238-46. [PMID: 15233660]
10. Bensoussan K, Fallone CA, Barkun AN, Martel M; RUGBE Investigators. A sampling of Canadian practice in managing nonvariceal upper gastrointestinal bleeding before recent guideline publication: is there room for improvement? Can J Gastroenterol. 2005;19:487-95. [PMID: 16107900]
11. Barkun A, Gasco A, Jewell D, Nevin K; the REASON Study Investigators. Management of nonvariceal upper GI bleeding (NVUGIB) after guideline publication: the REASON study [Abstract 87]. Can J Gastroenterol. 2006;20 Suppl A:80A.
12. Barkun A, Enns R, Romagnuolo J, Muller T, Kalmin T, Hawes I, et al. Drug Utilization Review of Acid Suppressants (DURABLE)—an audit to assess the utilization of proton pump inhibitors and histamine H2-receptor antagonists in Canadian hospitals [Abstract S1054]. Gastroenterology. 2008;134:A167.
13. Hearnshaw S, Logan R, Murphy M, Travis S, Palmer K. Results of the UK audit of 6750 patients with acute upper gastrointestinal haemorrhage. Gut. 2009. [Forthcoming].
14. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut. 2002;51 Suppl 4:iv1-6. [PMID: 12208839]
15. Barkun A, Bardou M, Marshall JK; Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003;139: 843-57. [PMID: 14623622]
16. Appraisal of Guidelines for Research & Evaluation (AGREE) Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. AGREE Collaboration; 2001.
17. Palda VA, Davis D, Goldman J. A guide to the Canadian Medical Association handbook on clinical practice guidelines. CMAJ. 2007;177:1221-6. [PMID: 17984472]
18. Hayes S, Hawes I, Dawes M, Barkun A. Assessment of reasons for nonadherence to nonvariceal upper gastrointestinal bleeding (NVUGIB) guidelines [Abstract P383]. Presented at the American College of Gastroenterology Annual Meeting, 12-17 October 2007, Philadelphia.
19. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. [PMID: 15205295]
20. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schu'nemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133:123S-131S. [PMID: 18574262]
21. Barkun A, Bardou M, Gralnek I. Erythromycin and other prokinetics in acute upper gastrointestinal bleeding? A meta-analysis [Abstract]. Gastroenterology. 2009;134.
22. Sreedharan A, Martin J, Leontiadis G, Forman D, Howden C, Moayyedi P. Does proton pump inhibitor (PPI) treatment initiated before endoscopy work in unselected upper gastrointestinal bleeding? A Cochrane systematic review update [Abstract]. Gastroenterology. 2009;134.
23. Barkun A, Wyse J, Romagnuolo J, Gralnek I, Bardou M. Should we be performing routine second-look endoscopy in acute peptic ulcer bleeding in 2009? A meta-analysis [Abstract]. Gastroenterology. 2009;134.
24. Leontiadis G, Martin J, Sharma V, Howden C. Proton pump inhibitor (PPI) treatment for peptic ulcer (PU) bleeding: an updated Cochrane metaanalysis of randomized controlled trials (RCTs) [Abstract]. Gastroenterology. 2009;134.
25. Calvet X, Barkun A, Kuipers E, Lanas A, Bardou M, Sung J. Is H. pylori testing clinically useful in the acute setting of upper gastrointestinal bleeding? A systematic review [Abstract]. Gastroenterology. 2009;134.
26. Cook DJ, Greengold NL, Ellrodt AG, Weingarten SR. The relation between systematic reviews and practice guidelines. Ann Intern Med. 1997;127: 210-6. [PMID: 9245227]
27. Dalkey N. An experimental study of group opinion: the Delphi Method. Futures. 1969:408-26.
28. Canadian Association of Gastroenterology. Policy on the Application for, and Implementation of, Clinical Practice Guidelines. Oakville, Ontario, Canada: Canadian Association of Gastroenterology; 2008.
29. American Accreditation Council for Continuing Medical Education. ACCME Standards for Commercial Support: Ethics Standards to Ensure the Independence of CME Activities. Chicago: American Accreditation Council for Continuing Medical Education; 2007. Accessed at www. accme.org/dir_docs /doc_upload/68b2902a-fb73-44d1-8725-80a1504e520c_uploaddocument.pdf on 23 November 2009.
30. Canadian Medical Association. Guidelines for Physicians in Interaction with Industry. Ottawa, Ontario, Canada: Canadian Medical Association; 2007.
31. Almela P, Benages A, Peiro' S, An'o'n R, Pe'rez MM, Pen'a A, et al. A risk score system for identification of patients with upper-GI bleeding suitable for outpatient management. Gastrointest Endosc. 2004;59:772-81. [PMID: 15173788]
32. Imperiale TF, Dominitz JA, Provenzale DT, Boes LP, Rose CM, Bowers JC, et al. Predicting poor outcome from acute upper gastrointestinal hemorrhage. Arch Intern Med. 2007;167:1291-6. [PMID: 17592103]
33. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318-21. [PMID: 11073021]
34. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316-21. [PMID: 8675081]
35. Masaoka T, Suzuki H, Hori S, Aikawa N, Hibi T. Blatchford scoring system is a useful scoring system for detecting patients with upper gastrointestinal bleeding who do not need endoscopic intervention. J Gastroenterol Hepatol. 2007;22:1404-8. [PMID: 17716345]
36. Robins GG, Sarwar MS, Armstrong M, Denyer ME, Bush S, Hassan T, et al. Evaluation of the need for endoscopy to identify low-risk patients presenting with an acute upper gastrointestinal bleed suitable for early discharge. Postgrad Med J. 2007;83:768-72. [PMID: 18057177]
37. Stanley AJ, Ashley D, Dalton HR, Mowat C, Gaya DR, Thompson E, et al. Outpatient management of patients with low-risk upper-gastrointestinalhaemorrhage: multicentre validation and prospective evaluation. Lancet. 2009; 373:42-7. [PMID: 19091393]
38. Romagnuolo J, Barkun AN, Enns R, Armstrong D, Gregor J. Simple clinical predictors may obviate urgent endoscopy in selected patients with nonvariceal upper gastrointestinal tract bleeding. Arch Intern Med. 2007;167:265-70. [PMID: 17296882]
39. Chen IC, Hung MS, Chiu TF, Chen JC, Hsiao CT. Risk scoring systems topredict need for clinical intervention for patients with nonvariceal upper gastrointestinal tract bleeding. Am J Emerg Med. 2007;25:774-9. [PMID: 17870480]
40. Lin HJ, Perng CL, Lee FY, Lee CH, Lee SD. Clinical courses and predictors for reb-leeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study. Gut. 1994;35:1389-93. [PMID: 7959193]
41. Villanueva C, Balanzo' J, Espino's JC, Domenech JM, Sa'inz S, Call J, et al. Prediction of therapeutic failure in patients with bleeding peptic ulcer treated with endoscopic injection. Dig Dis Sci. 1993;38:2062-70. [PMID: 8223082]
42. Brullet E, Campo R, Calvet X, Coroleu D, Rivero E, Simo' Deu J. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut. 1996;39:155-8. [PMID: 8977333]
43. Lai KH, Peng SN, Guo WS, Lee FY, Chang FY, Malik U, et al. Endoscopic injection for the treatment of bleeding ulcers: local tamponade or drug effect? Endoscopy. 1994;26:338-41. [PMID: 8076564]
44. Camellini L, Merighi A, Pagnini C, Azzolini F, Guazzetti S, Scarcelli A, et al. Comparison of three different risk scoring systems in non-variceal upper gastrointestinal bleeding. Dig Liver Dis. 2004;36:271-7. [PMID: 15115340]
45. Vreeburg EM, Terwee CB, Snel P, Rauws EA, Bartelsman JF, Meulen JH, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut. 1999;44:331-5. [PMID: 10026316]
46. Enns RA, Gagnon YM, Barkun AN, Armstrong D, Gregor JC, Fedorak RN; RUGBE Investigators Group. Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting. World J Gastroenterol. 2006;12:7779-85. [PMID: 17203520]
47. Church NI, Dallal HJ, Masson J, Mowat NA, Johnston DA, Radin E, et al. Validity of the Rockall scoring system after endoscopic therapy for bleeding pepticulcer: a prospective cohort study. Gastrointest Endosc. 2006;63:606-12. [PMID: 16564860]
48. Soncini M, Triossi O, Leo P, Magni G, Bertele' AM, Grasso T, et al. Management of patients with nonvariceal upper gastrointestinal hemorrhage before and after the adoption of the Rockall score, in the Italian Gastroenterology Units. Eur J Gastroenterol Hepatol. 2007;19:543-7. [PMID: 17556899]
49. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198-208. [PMID: 16810012]
50. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36:2667-74. [PMID: 18679112]
51. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al; International Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327. [PMID: 18158437]
52. He'bert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17. [PMID: 9971864]
53. Bellotto F, Fagiuoli S, Pavei A, Gregory SA, Cati A, Silverj E, et al. Anemia and ischemia: myocardial injury in patients with gastrointestinal bleeding. Am J Med. 2005;118:548-51. [PMID: 15866259]
54. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39:1070-7. [PMID: 10532600]
55. Barkun A, Bardou M, Gralnek I, Shingina A, Razzaghi A, Rostom A. Impact of elevated INR and of low platelet count on outcomes in acute upper GI bleeding (UGIB) [Abstract]. Gastroenterology. 2009;134.
56. Wolf AT, Wasan SK, Saltzman JR. Impact of anticoagulation on reb-leeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage. Am J Gastroenterol. 2007;102:290-6. [PMID: 17100959]
57. Baradarian R, Ramdhaney S, Chapalamadugu R, Skoczylas L, Wang K, Rivilis S, et al. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am J Gastroenterol. 2004;99:619-22. [PMID: 15089891]
58. Choudari CP, Rajgopal C, Palmer KR. Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment. Gut. 1994;35:464-6. [PMID: 8174982]
59. Tripodi A, Caldwell SH, Hoffman M, Trotter JF, Sanyal AJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther. 2007;26:141-8. [PMID: 17593061]
60. Coffin B, Pocard M, Panis Y, Riche F, Laine' MJ, Bitoun A, et al. Groupe des endoscopistes de garde a' lAP-HP. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc. 2002;56:174-9. [PMID: 12145593]
61. Carbonell N, Pauwels A, Serfaty L, Boelle PY, Becquemont L, Poupon R. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol. 2006;101: 1211-5. [PMID: 16771939]
62. Frossard JL, Spahr L, Queneau PE, Giostra E, Burckhardt B, Ory G, et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology. 2002;123:17-23. [PMID: 12105828]
63. Habashi S, Lambiase L, Kottoor R. Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: A randomized, controlled, double-blind & placebo-controlled trial [Abstract]. Am J Gastroenterol. 2007;102:S526.
64. Sussman D, Deshpande A, Parra J, Ribeiro A. Intravenous metoclopramide to increase mucosal visualization during endoscopy in patients with acute upper gastrointestinal bleeding: a randomized, controlled study [Abstract T1558]. Gastrointest Endosc. 2008;67:AB247.
65. Winstead NS, Wilcox CM. Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2007;26:1371-7. [PMID: 17848180]
66. Cipolletta L, Bianco MA, Rotondano G, Marmo R, Piscopo R. Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc. 2002;55:1-5. [PMID: 11756905]
67. Hsu PI, Lai KH, Lin XZ, Yang YF, Lin M, Shin JS, et al. When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of reb-leeding. Gastrointest Endosc. 1996;44:382-7. [PMID: 8905354]
68. Lai KC, Hui WM, Wong BC, Ching CK, Lam SK. A retrospective and prospective study on the safety of discharging selected patients with duodenal ulcer bleeding on the same day as endoscopy. Gastrointest Endosc. 1997;45:26- 30. [PMID: 9013166]
69. Longstreth GF, Feitelberg SP. Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc. 1998;47:219-22. [PMID: 9540873]
70. Gisbert JP, Legido J, Castel I, Trapero M, Cantero J, Mate' J, et al. Risk assessment and outpatient management in bleeding peptic ulcer. J Clin Gastroenterol. 2006;40:129-34. [PMID: 16394873]
71. Spiegel BM, Vakil NB, Ofman JJ. Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: is sooner better? A systematic review. Arch Intern Med. 2001;161:1393-404. [PMID: 11386888]
72. Hay JA, Maldonado L, Weingarten SR, Ellrodt AG. Prospective evaluation of a clinical guideline recommending hospital length of stay in upper gastrointestinal tract hemorrhage. JAMA. 1997;278:2151-6. [PMID: 9417008]
73. Moreno P, Jaurrieta E, Aranda H, Fabregat J, Farran L, Biondo S, et al. Efficacy and safety of an early discharge protocol in low-risk patients with upper gastrointestinal bleeding. Am J Med. 1998;105:176-81. [PMID: 9753019]
74. Oei TT, Dulai GS, Gralnek IM, Chang D, Kilbourne AM, Sale GA. Hospital care for low-risk patients with acute, nonvariceal upper GI hemorrhage: a comparison of neighboring community and tertiary care centers. Am J Gastroenterol. 2002;97:2271-8. [PMID: 12358244]
75. Bjorkman DJ, Zaman A, Fennerty MB, Lieberman D, Disario JA, Guest- Warnick G. Urgent vs. elective endoscopy for acute non-variceal upper-GI bleeding: an effectiveness study. Gastrointest Endosc. 2004;60:1-8. [PMID: 15229417]
76. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008;359:928-37. [PMID: 18753649]
77. Dorward S, Sreedharan A, Leontiadis GI, Howden CW, Moayyedi P, Forman D. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2006: CD005415. [PMID: 17054257]
78. Naumovski-Mihalic S, Katicic M, Colic-Cvlje V, Bozek T, Prskalo M, Sabaric B, et al. Intravenous proton pump inhibitor in ulcer bleeding in patients admitted to an intensive care unit [Abstract W1578]. Gastroenterology. 2005; 128:A641.
79. Lau JY, Leung WK, Wu JC, Chan FK, Wong VW, Chiu PW, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med. 2007;356:1631-40. [PMID: 17442905]
80. Al-Sabah S, Barkun AN, Herba K, Adam V, Fallone C, Mayrand S, et al. Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2008;6:418-25. [PMID: 18304891]
81. Barkun AN. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy? [Editorial]. Gastrointest Endosc. 2008;67:1064-6. [PMID: 18513549]
82. Tsoi KK, Lau JY, Sung JJ. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding. Gastrointest Endosc. 2008;67:1056-63. [PMID: 18407271]
83. Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess. 2007;11:iii-iv, 1-164. [PMID: 18021578]
84. Lin HJ, Wang K, Perng CL, Chua RT, Lee FY, Lee CH, et al. Early or delayed endoscopy for patients with peptic ulcer bleeding. A prospective randomized study. J Clin Gastroenterol. 1996;22:267-71. [PMID: 8771420]
85. Lee JG, Turnipseed S, Romano PS, Vigil H, Azari R, Melnikoff N, et al. Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc. 1999;50:755-61. [PMID: 10570332]
86. Rockall TA, Logan RF, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet. 1996; 347:1138-40. [PMID: 8609747]
87. Ananthakrishnan AN, McGinley EL, Saeian K. Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis. Clin Gastroenterol Hepatol. 2009;7:296-302e1. [PMID: 19084483]
88. Cooper GS, Kou TD, Wong RC. Use and impact of early endoscopy in elderly patients with peptic ulcer hemorrhage: a population-based analysis. Gastrointest Endosc. 2009;70:229-35. [PMID: 19329112]
89. Tai CM, Huang SP, Wang HP, Lee TC, Chang CY, Tu CH, et al. High- risk ED patients with nonvariceal upper gastrointestinal hemorrhage undergoing emergency or urgent endoscopy: a retrospective analysis. Am J Emerg Med. 2007;25:273-8. [PMID: 17349900]
90. Targownik LE, Murthy S, Keyvani L, Leeson S. The role of rapid endoscopy for high-risk patients with acute nonvariceal upper gastrointestinal bleeding. Can J Gastroenterol. 2007;21:425-9. [PMID: 17637943]
91. Schacher GM, Lesbros-Pantoflickova D, Ortner MA, Wasserfallen JB, Blum AL, Dorta G. Is early endoscopy in the emergency room beneficial in patients with bleeding peptic ulcer? A "fortuitously controlled" study. Endoscopy. 2005;37:324-8. [PMID: 15824941]
92. Adamopoulos AB, Baibas NM, Efstathiou SP, Tsioulos DI, Mitromaras AG, Tsami AA, et al. Differentiation between patients with acute upper gastrointestinal bleeding who need early urgent upper gastrointestinal endoscopy and those who do not. A prospective study. Eur J Gastroenterol Hepatol. 2003;15: 381-7. [PMID: 12655258]
93. Lin HJ, Wang K, Perng CL, Lee FY, Lee CH, Lee SD. Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation. Gastrointest Endosc. 1996;43:470-3. [PMID: 8726760]
94. Laine L, Stein C, Sharma V. A prospective outcome study of patients with clot in an ulcer and the effect of irrigation. Gastrointest Endosc. 1996;43:107-10. [PMID: 8635701]
95. Sung JJ, Chan FK, Lau JY, Yung MY, Leung WK, Wu JC, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med. 2003;139:237-43. [PMID: 12965978]
96. Lau JY, Chung SC, Leung JW, Lo KK, Yung MY, Li AK. The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study. Endoscopy. 1998;30:513-8. [PMID: 9746158]
97. Bleau BL, Gostout CJ, Sherman KE, Shaw MJ, Harford WV, Keate RF, et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc. 2002;56:1-6. [PMID: 12085028]
98. Jensen DM, Kovacs TO, Jutabha R, Machicado GA, Gralnek IM, Savides TJ, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology. 2002;123: 407-13. [PMID: 12145792]
99. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidencebased approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009;7:33-47; quiz 1-2. [PMID: 18986845]
100. Kahi CJ, Jensen DM, Sung JJ, Bleau BL, Jung HK, Eckert G, et al. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology. 2005;129:855-62. [PMID: 16143125]
101. Laine L. Systematic review of endoscopic therapy for ulcers with clots: Can a meta-analysis be misleading? [Letter]. Gastroenterology. 2005;129:2127; author reply 2127-8. [PMID: 16344090]
102. Marmo R, Rotondano G, Piscopo R, Bianco MA, D'Angella R, Cipolletta L. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol. 2007; 102:279-89; quiz 469. [PMID: 17311650]
103. Sung JJ, Tsoi KK, Lai LH, Wu JC, Lau JY. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007;56:1364-73. [PMID: 17566018]
104. Yuan Y, Wang C, Hunt RH. Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials. Gastrointest Endosc. 2008;68:339-51. [PMID: 18656600]
105. Vergara M, Calvet X, Gisbert JP. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers. Cochrane Database Syst Rev. 2007:CD005584. [PMID: 17443601]
106. Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc. 2009;69:786-99. [PMID: 19152905]
107. Calvet X, Vergara M, Brullet E, Gisbert JP, Campo R. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology. 2004;126:441-50. [PMID: 14762781]
108. Gevers AM, De Goede E, Simoens M, Hiele M, Rutgeerts P. A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcers. Gastrointest Endosc. 2002;55:466-9. [PMID: 11923755]
109. Chung SC, Leung JW, Sung JY, Lo KK, Li AK. Injection or heat probe for bleeding ulcer. Gastroenterology. 1991;100:33-7. [PMID: 1983848]
110. Chiu PW, Lam CY, Lee SW, Kwong KH, Lam SH, Lee DT, et al. Effect of scheduled second therapeutic endoscopy on peptic ulcer reb-leeding: a prospective randomised trial. Gut. 2003;52:1403-7. [PMID: 12970130]
111. Messmann H, Schaller P, Andus T, Lock G, Vogt W, Gross V, et al. Effect of programmed endoscopic follow-up examinations on the reb-leeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy. 1998;30:583-9. [PMID: 9826134]
112. Villanueva C, Balanzo' J, Torras X, Soriano G, Sa'inz S, Vilardell F. Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial. Gastrointest Endosc. 1994;40:34-9. [PMID: 8163132]
113. Saeed ZA, Cole RA, Ramirez FC, Schneider FE, Hepps KS, Graham DY. Endoscopic retreatment after successful initial hemostasis prevents ulcer reb-leeding: a prospective randomized trial. Endoscopy. 1996;28:288-94. [PMID: 8781792]
114. Rutgeerts P, Rauws E, Wara P, Swain P, Hoos A, Solleder E, et al. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet. 1997;350:692-6. [PMID: 9291903]
115. Chiu P, Choi C, Kwong K-H, Lam S. The effect of scheduled second endoscopy against intravenous high dose omeprazole infusion as an adjunct to therapeutic endoscopy in prevention of peptic ulcer reb-leeding—a prospective randomized study [Abstract]. Gastroenterology. 2006;130:A121.
116. Lee S, Cho C, Tak W, Kweon Y, Kim S, Choi Y. The effect of second look endoscopy in patients with bleeding peptic ulcers [Abstract]. Gastroenterology. 2005;128:A639.
117. Lin C, Lai K, Lo G, Cheng J, Huang R, Hsu P, et al. The value of secondlook endoscopy after endoscopic injection for bleeding peptic ulcer [Abstract]. Gastroenterology. 1996;110:A177.
118. Ell C; German Study Group. Scheduled endoscopic retreatment vs. single injection therapy in bleeding gastroduodenal ulcers: results of a multicenter study [Abstract]. Gastrointest Endosc. 1998;47:A883.
119. Marmo R, Rotondano G, Bianco MA, Piscopo R, Prisco A, Cipolletta L. Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc. 2003;57:62-7. [PMID: 12518133]
120. Chiu P-Y, Lau T-S, Kwong K-H, Suen D-K, Kwok S-Y. Impact of programmed second endoscopy with appropriate re-treatment on peptic ulcer bleeding: A systematic review. Ann Coll Surg H-K. 2003;7:106-15.
121. Tsoi K, Chan H, Pao C, Chiu P, Sung J. Is second-look endoscopy with heater probe or injection for peptic ulcer bleeding necessary [Abstract]? Gut. 2008;57:A355.
122. Spiegel BM, Ofman JJ, Woods K, Vakil NB. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. Am J Gastroenterol. 2003;98:86-97. [PMID: 12526942]
123. Romagnuolo J. Routine second look endoscopy: ineffective, costly and potentially misleading. Can J Gastroenterol. 2004;18:401-4. [PMID: 15190397]
124. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2006: CD002094. [PMID: 16437441]
125. Sung JJ, Barkun A, Kuipers EJ, Mo'ssner J, Jensen DM, Stuart R, et al. Peptic Ulcer Bleed Study Group. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2009;150: 455-64. [PMID: 19221370]
126. Wei KL, Tung SY, Sheen CH, Chang TS, Lee IL, Wu CS. Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. J Gastroenterol Hepatol. 2007;22:43-6. [PMID: 17201879]
127. Naumovski-Mihalic S, Katicic M, Bozek T, Colic-Cvlje V, Sabaric B, Prskalo M, et al. Gastric acid suppression in acute ulcer bleeding in patients with comorbid illness [Abstract]. Gut. 2007;56:A234.
128. Lin HJ, Lo WC, Cheng YC, Perng CL. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am J Gastroenterol. 2006;101:500-5. [PMID: 16542286]
129. Zargar SA, Javid G, Khan BA, Yattoo GN, Shah AH, Gulzar GM, et al. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. J Gastroenterol Hepatol. 2006;21:716-21. [PMID: 16677158]
130. Khoshbaten M, Fattahi E, Naderi N, Khaleghian F, Rezailashkajani M. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer. BMC Gastroenterol. 2006;6:2. [PMID: 16403233]
131. Hsu PI, Lo GH, Lo CC, Lin CK, Chan HH, Wu CJ, et al. Intravenous pantoprazole versus ranitidine for prevention of reb-leeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol. 2004;10:3666-9. [PMID: 15534928]
132. Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2004;19:591-600. [PMID: 14987328]
133. Lee KK, You JH, Wong IC, Kwong SK, Lau JY, Chan TY, et al. Costeffectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointest Endosc. 2003;57: 160-4. [PMID: 12556776]
134. Erstad BL. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding. Crit Care Med. 2004;32:1277-83. [PMID: 15187506]
135. Focareta R, Ciarleglio A, Piai G, Ievoli F, Forte G. Proton-pump inhibitor and acute peptic ulcer bleeding: effectiveness of oral esomeprazole vs. intravenous omeprazole in reducing the risk of recurrent bleeding [Abstract]. Dig Liver Dis. 2004;36:S250.
136. Jang J, Dong S, Jung J, Chae M, Kim N, Lee S, et al. High-dose oral proton pump inhibitor is as effective as intravenous administration in the aspect of increasing pH and reducing reb-leeding after endoscopic treatment of bleeding peptic ulcers [Abstract]. Gastroenterology. 2006;103:A467.
137. Bajaj JS, Dua KS, Hanson K, Presberg K. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on reb-leeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Dig Dis Sci. 2007;52: 2190-4. [PMID: 17429726]
138. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171:33-8. [PMID: 15238493]
139. Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008;103:2308-13. [PMID: 18702653]
140. Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343:310-6. [PMID: 10922420]
141. Jensen DM, Pace SC, Soffer E, Comer GM; 315 Study Group. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer reb-leeding: a U.S. multicenter randomized, double-blind study. Am J Gastroenterol. 2006; 101:1991-9; quiz 2170. [PMID: 16968504]
142. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents reb-leeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998; 158:54-8. [PMID: 9437379]
143. Klok RM, Postma MJ, van Hout BA, Brouwers JR. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment Pharmacol Ther. 2003;17:1237-45. [PMID: 12755837]
144. Armstrong D, Marshall JK, Chiba N, Enns R, Fallone CA, Fass R, et al; Canadian Association of Gastroenterology GERD Consensus Group. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults-update 2004. Can J Gastroenterol. 2005;19:15-35. [PMID: 15685294]
145. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989-95. [PMID: 16414946]
146. Roughead EE, Ramsay EN, Pratt NL, Ryan P, Gilbert AL. Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia. Med J Aust. 2009;190:114-6. [PMID: 19203305]
147. Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ. 2008; 179:319-26. [PMID: 18695179]
148. Hsu PI, Lin XZ, Chan SH, Lin CY, Chang TT, Shin JS, et al. Bleeding peptic ulcer—risk factors for reb-leeding and sequential changes in endoscopic findings. Gut. 1994;35:746-9. [PMID: 8020797]
149. Brullet E, Campo R, Calvet X, Guell M, Garcia-Monforte N, Cabrol J. A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection. Gastrointest Endosc. 2004;60:15-21. [PMID: 15229419]
150. Cooper GS, Kou TD, Wong RC. Outpatient management of nonvariceal upper gastrointestinal hemorrhage: unexpected mortality in Medicare beneficiaries. Gastroenterology. 2009;136:108-14. [PMID: 19010328]
151. Elmunzer BJ, Young SD, Inadomi JM, Schoenfeld P, Laine L. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol. 2008;103:2625-32; quiz 2633. [PMID: 18684171]
152. Chiu PW, Ng EK, Cheung FK, Chan FK, Leung WK, Wu JC, et al. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol. 2009;7:311-6; quiz 253. [PMID: 18955161]
153. Romagnuolo J, Flemons WW, Perkins L, Lutz L, Jamieson PC, Hiscock CA, et al. Post-endoscopy checklist reduces length of stay for non-variceal upper gastrointestinal bleeding. Int J Qual Health Care. 2005;17:249-54. [PMID: 15760910]
154. Kim S, Duddalwar V. Failed endoscopic therapy and the interventional radiologist: non-variceal upper gastrointestinal bleeding. Tech Gastrointest Endosc. 2005;7:148-55.
155. Ljungdahl M, Eriksson LG, Nyman R, Gustavsson S. Arterial embolisation in management of massive bleeding from gastric and duodenal ulcers. Eur J Surg. 2002;168:384-90. [PMID: 12463427]
156. Defreyne L, Vanlangenhove P, De Vos M, Pattyn P, Van Maele G, Decruyenaere J, et al. Embolization as a first approach with endoscopically unmanageable acute nonvariceal gastrointestinal hemorrhage. Radiology. 2001;218: 739-48. [PMID: 11230648]
157. Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, et al. Transcatheter arterial embolization for massive bleeding from duodenal ulcers not controlled by endoscopic hemostasis. Endoscopy. 1995;27:304-7. [PMID: 7555935]
158. Holme JB, Nielsen DT, Funch-Jensen P, Mortensen FV. Transcatheter arterial embolization in patients with bleeding duodenal ulcer: an alternative to surgery. Acta Radiol. 2006;47:244-7. [PMID: 16613304]
159. Loffroy R, Guiu B, Cercueil JP, Lepage C, Latournerie M, Hillon P, et al. Refractory bleeding from gastroduodenal ulcers: arterial embolization in highoperative- risk patients. J Clin Gastroenterol. 2008;42:361-7. [PMID: 18277904]
160. Ripoll C, Ban'ares R, Beceiro I, Menche'n P, Catalina MV, Echenagusia A, et al. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol. 2004;15:447-50. [PMID: 15126653]
161. Poultsides GA, Kim CJ, Orlando R 3rd, Peros G, Hallisey MJ, Vignati PV. Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg. 2008;143:457-61. [PMID: 18490553]
162. Lau JY, Sung JJ, Lam YH, Chan AC, Ng EK, Lee DW, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med. 1999;340:751-6. [PMID: 10072409]
163. Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez- Mun'oz E. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther. 2004;19:617-29. [PMID: 15023164]
164. Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101:848-63. [PMID: 16494583]
165. Wildner-Christensen M, Touborg Lassen A, Lindebjerg J, Schaffalitzky de Muckadell OB. Diagnosis of Helicobacter pylori in bleeding peptic ulcer patients, evaluation of urea-based tests. Digestion. 2002;66:9-13. [PMID: 12379809]
166. Tu TC, Lee CL, Wu CH, Chen TK, Chan CC, Huang SH, et al. Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers. Gastrointest Endosc. 1999;49:302-6. [PMID: 10049412]
167. Grin'o' P, Pascual S, Such J, Casellas JA, Niveiro M, Andreu M, et al. Comparison of diagnostic methods for Helicobacter pylori infection in patients with upper gastrointestinal bleeding. Scand J Gastroenterol. 2001;36:1254-8. [PMID: 11761013]
168. Chung IK, Hong SJ, Kim EJ, Cho JY, Kim HS, Park SH, et al. What is the best method to diagnose Helicobacter infection in bleeding peptic ulcers?: a prospective trial. Korean J Intern Med. 2001;16:147-52. [PMID: 11769572]
169. Peitz U, Leodolter A, Kahl S, Agha-Amiri K, Wex T, Wolle K, et al. Antigen stool test for assessment of Helicobacter pylori infection in patients with upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2003;17:1075-84. [PMID: 12694090]
170. Grin'o' P, Pascual S, Such J, Casellas JA, Niveiro M, Andreu M, et al. Comparison of stool immunoassay with standard methods for detection of Helicobacter pylori infection in patients with upper-gastrointestinal bleeding of peptic origin. Eur J Gastroenterol Hepatol. 2003;15:525-9. [PMID: 12702910]
171. Lo CC, Lai KH, Peng NJ, Lo GH, Tseng HH, Lin CK, et al. Polymerase chain reaction: a sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers. World J Gastroenterol. 2005;11:3909-14. [PMID: 15991292]
172. Hanvivatvong O, Thong-Ngam D, Kuakarn S, Mahachai V. Evaluation of Helicobacter pylori stool antigen test in Thai patients with upper gastrointestinal bleeding. J Med Assoc Thai. 2006;89 Suppl 3:S98-103. [PMID: 17722307]
173. Gu"ell M, Artigau E, Esteve V, Sa'nchez-Delgado J, Junquera F, Calvet X. Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer. Aliment Pharmacol Ther. 2006;23:53-9. [PMID: 16393280]
174. Liao CC, Lee CL, Lai YC, Huang SH, Lee SC, Wu CH, et al. Accuracy of three diagnostic tests used alone and in combination for detecting Helicobacter pylori infection in patients with bleeding gastric ulcers. Chin Med J (Engl). 2003; 116:1821-6. [PMID: 14687466]
175. Colin R, Czernichow P, Baty V, Touze' I, Brazier F, Bretagne JF, et al. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer. Gastroenterol Clin Biol. 2000;24:31-5. [PMID: 10679585]
176. Lee JM, Breslin NP, Fallon C, O'Morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am J Gastroenterol. 2000;95:1166-70. [PMID: 10811322]
177. van Leerdam ME, van der Ende A, ten Kate FJ, Rauws EA, Tytgat GN. Lack of accuracy of the noninvasive Helicobacter pylori stool antigen test in patients with gastroduodenal ulcer bleeding. Am J Gastroenterol. 2003;98:798-801. [PMID: 12738458]
178. Castro-Ferna'ndez M, Sa'nchez-Mun'oz D, Garci'a-Di'az E, Miralles-Sanchiz J, Vargas-Romero J. Diagnosis of Helicobacter pylori infection in patients with bleeding ulcer disease: rapid urease test and histology. Rev Esp Enferm Dig. 2004;96:395-8; 398-401. [PMID: 15230669]
179. Gisbert JP, Esteban C, Jimenez I, Moreno-Otero R. 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding. Helicobacter. 2007;12:231-7. [PMID: 17493003]
180. Winiarski M, Bielanski W, Plonka M, Dobrzanska M, Kaminska A, Bobrzynski A, et al. The usefulness of capsulated 13C-urea breath test in diagnosis of Helicobacter pylori infection in patients with upper gastrointestinal bleeding. J Clin Gastroenterol. 2003;37:34-8. [PMID: 12811206]
181. Liao C. Biopsy-based diagnostic test lack sensitivity for detection of Helicobacter pylori infection in patients with bleeding duodenal ulcers [Abstract]. Gut. 2001;49:A102.
182. Schilling D, Demel A, Adamek HE, Nu"sse T, Weidmann E, Riemann JF. A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study. Dig Liver Dis. 2003;35:217-21. [PMID: 12801031]
183. Lai K, Hui W, Lam S. Bleeding ulcers have high false negative rates for antral Helicobacter pylori when tested with urease test [Abstract]. Gastroenterology. 1996;110:A167.
184. Archimandritis A, Tzivras M, Sougioultzis S, Papaparaskevas I, Apostolopoulos P, Avlami A, et al. Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non-variceal upper gastrointestinal bleeding. J Gastroenterol Hepatol. 2000;15:369-73. [PMID: 10824879]
185. Gisbert JP, Trapero M, Calvet X, Mendoza J, Quesada M, Gu"ell M, et al. Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2004;19:923-9. [PMID: 15080854]
186. Lin HJ, Lo WC, Perng CL, Li AF, Tseng GY, Sun IC, et al. Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers. Helicobacter. 2004;9:663-8. [PMID: 15610081]
187. Demiray E, Yilmaz O, Sarkis C, Soyturk M, Simsek I. Comparison of invasive methods and two different stool antigen tests for diagnosis of H. pylori infection in patients with gastric bleeding. World J Gastroenterol. 2006;12:4206- 10. [PMID: 16830376]
188. Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther. 2009;29:481-96. [PMID: 19053986]
189. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2008;118:1894-909. [PMID: 18836135]
190. Chan FK, Abraham NS, Scheiman JM, Laine L; First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Antiinflammatory Drugs and Anti-platelet Agents. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol. 2008;103:2908-18. [PMID: 18853980]
191. Chan FK, Hung LC, Suen BY, Wong VW, Hui AJ, Wu JC, et al. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology. 2004;127:1038-43. [PMID: 15480981]
192. Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med. 2002;347:2104-10. [PMID: 12501222]
193. Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, et al. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Am J Med. 2005;118:1271-8. [PMID: 16271912]
194. Targownik LE, Metge CJ, Leung S, Chateau DG. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal antiinflammatory drugs. Gastroenterology. 2008;134:937-44. [PMID: 18294634]
195. Rahme E, Barkun AN, Toubouti Y, Scalera A, Rochon S, Lelorier J. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? Arthritis Rheum. 2007;57:748-55. [PMID: 17530673]
196. Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a doubleblind, randomised trial. Lancet. 2007;369:1621-6. [PMID: 17499604]
197. Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP; MEDAL Steering Committee. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long- term (MEDAL) programme: a randomised comparison. Lancet. 2007;369:465-73. [PMID: 17292766]
198. Chan F, Wong V, Wu J, Sung J. Combination of a cyclooxygenase (COX)-2 selective NSAID and a proton pump inhibitor for prevention of gastroduodenal ulcers in very high risk patients: a one-year, double-blind, randomized trial [Abstract]. Gastroenterology. 2008;134:A114.
199. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006;101:701-10. [PMID: 16494585]
200. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal antiinflammatory drugs increase the risk of atherothrombosis? Metaanalysis of randomised trials. BMJ. 2006;332:1302-8. [PMID: 16740558]
201. Rostom A, Dube' C, Lewin G, Tsertsvadze A, Barrowman N, Code C, et al; U.S. Preventive Services Task Force. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;146:376-89. [PMID: 17339623]
202. Maetzel A, Krahn M, Naglie G. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Arthritis Rheum. 2003;49:283-92. [PMID: 12794781]
203. El-Serag HB, Graham DY, Richardson P, Inadomi JM. Prevention of complicated ulcer disease among chronic users of nonsteroidal antiinflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002;162:2105-10. [PMID: 12374519]
204. Spiegel BM, Chiou CF, Ofman JJ. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis Rheum. 2005;53:185-97. [PMID: 15818647]
205. Aguejouf O, Eizayaga F, Desplat V, Belon P, Doutremepuich C. Prothrombotic and hemorrhagic effects of aspirin. Clin Appl Thromb Hemost. 2009;15:523-8. [PMID: 18603541]
206. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27:2667-74. [PMID: 17053008]
207. Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004;62:1187-9. [PMID: 15079022]
208. Burger W, Chemnitius JM, Kneissl GD, Ru'cker G. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med. 2005;257:399-414. [PMID: 15836656]
209. Sung J, Lau J, Ching J, Leung W, Wu J, Leung V, et al. Early reintroduction of aspirin with proton pump inhibitor after endoscopic hemostasis for peptic ulcer bleeding: final results of a double blinded randomized study [Abstract OPG- 121]. Gut. 2007;56:A27.
210. Ng FH, Wong BC, Wong SY, Chen WH, Chang CM. Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/ re-bleeding risk - a single-blind, randomized controlled study. Aliment Pharmacol Ther. 2004;19: 359-65. [PMID: 14984383]
211. Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238-44. [PMID: 15659723]
212. Lai KC, Chu KM, Hui WM, Wong BC, Hung WK, Loo CK, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol. 2006;4:860-5. [PMID: 16797240]
213. Small DS, Farid NA, Payne CD, Weerakkody GJ, Li YG, Brandt JT, et al. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol. 2008;48:475- 84. [PMID: 18303127]
214. Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 2008;51:256-60. [PMID: 18206732]
215. O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet. 2009;374:989-97. [PMID: 19726078]
216. Sadowski DC. Proton Pump Inhibitors and Clopidogrel—What is the Current Status? Oakville, Ontario, Canada: Canadian Association of Gastroenterology; 2009.
217. Chong E, Ensom MH. Pharmacogenetics of the proton pump inhibitors: a systematic review. Pharmacotherapy. 2003;23:460-71. [PMID: 12680476]
218. Moayyedi P, Sadowski DC. Proton pump inhibitors and clopidogrelhazardous drug interaction or hazardous interpretation of data? [Editorial]. Can J Gastroenterol. 2009;23:251-2. [PMID: 19373416]
219. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180:713-8. [PMID: 19176635]
220. Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301: 937-44. [PMID: 19258584]
221. Dunn S, Macaulay T, Brennan D, Campbell C, Charnigo R, Smyth S, et al. Baseline proton pump inhibitor use is associated with increased cardiovascular events with and without the use of clopidogrel in the CREDO trial [Abstract]. Circulation. 2008;118:S815.
222. Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Me'neveau N, et al; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med. 2009;360:363-75. [PMID: 19106083]
223. American College of Cardiology (ACC), American College of Gastroenterology (ACG), American Heart Association (AHA). Joint comment on studies regarding possible interaction of clopidogrel and proton pump inhibitors [News release]. Dallas: American Heart Assoc; 11 November 2008.
224. U.S. Food and Drug Administration. Plavix (clopidogrel bisulfate) 75 mg tablets. Detailed view: safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER)—May 2009. Silver Spring, MD: U.S. Food and Drug Administration; 2009.
225. Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64:935-51. [PMID: 18679668]
Предыдущий раздел | Содержание
